Aarti Pharma

{
  "main_header": {
    "sid": 1003784,
    "name": "Aarti Pharma",
    "stock_name": "Aarti Pharma",
    "full_name": "Aarti Pharmalabs Ltd",
    "name_url": "stocks-analysis/aarti-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "710.65",
    "chg": -0.4,
    "chgp": "-0.06%",
    "dir": -1,
    "prev_price": "711.05",
    "mcapval": "6,464.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543748,
    "symbol": "AARTIPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0LRU01027",
    "curr_date": "Jun 24, 03:30 PM",
    "curr_time": "04:08 AM",
    "last_traded_at": "Jun 24, 03:30 PM IST",
    "bse_nse_vol": "2.81 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aarti-pharma-1003784-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Pharmalabs Ltd Surges 7.53% to Day's High of Rs 735 — Outperforms Sector by 6.13 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-hits-intraday-high-with-753-surge-on-23-jun-2026-4068826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_priceRelatedfactors_4068826.png",
        "date": "2026-06-23 10:02:34",
        "description": "The Sensex edged up 0.10% on 23 Jun 2026, while Aarti Pharmalabs Ltd surged 7.53% to touch an intraday high of Rs 735, outperforming its Pharmaceuticals & Biotechnology sector by 6.13 percentage points. This sharp single-session gain stands out as a significant stock-specific event amid a broadly positive but modest market advance."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4068236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4068236.png",
        "date": "2026-06-23 08:07:58",
        "description": "Aarti Pharmalabs Ltd has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook as of mid-June 2026. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, reflecting both caution and pockets of bullishness amid broader market pressures."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4066695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4066695.png",
        "date": "2026-06-22 08:03:39",
        "description": "Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a 5.01% gain on 22 Jun 2026, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-sell-4065997",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_mojoScore_4065997.png",
        "date": "2026-06-21 10:10:35",
        "description": "Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4060481",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4060481.png",
        "date": "2026-06-18 08:05:31",
        "description": "Aarti Pharmalabs Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 1.59%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish undertone."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Bearish Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-bearish-indicators-4058265",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4058265.png",
        "date": "2026-06-17 08:06:37",
        "description": "Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day decline of 0.14%, the stock’s technical parameters, including MACD, RSI, Bollinger Bands, and moving averages, reveal a complex picture that investors must carefully analyse amid broader market pressures."
      },
      {
        "title": "Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-technical-momentum-shifts-amid-mixed-market-signals-4055223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4055223.png",
        "date": "2026-06-16 08:07:38",
        "description": "Aarti Pharmalabs Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a slight decline in the stock price to ₹639.80, the evolving signals from MACD, RSI, moving averages, and other momentum indicators suggest cautious investor sentiment amid broader market pressures."
      },
      {
        "title": "Aarti Pharmalabs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aarti-pharmalabs-ltd-is-rated-strong-sell-4043909",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_mojoScore_4043909.png",
        "date": "2026-06-10 10:11:04",
        "description": "Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Aarti Pharmalabs Ltd Faces Intensified Downtrend Amid Technical Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aarti-pharmalabs-ltd-faces-intensified-downtrend-amid-technical-weakness-4040278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AartiPharmalabs_technicaldot_4040278.png",
        "date": "2026-06-09 08:05:27",
        "description": "Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters such as MACD, moving averages, and Bollinger Bands, underscores mounting selling pressure amid a challenging market backdrop for the pharmaceuticals sector."
      }
    ],
    "total": 311,
    "sid": "1003784",
    "stock_news_url": "https://www.marketsmojo.com/news/aarti-pharmalabs-1003784"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "01-Jun-2026",
      "details": "Transcript of Q4 FY 26 Earnings Conference Call.",
      "source": "BSE"
    },
    {
      "caption": "Audited Financial Results For The Quarter And Financial Year Ended March 31 2026",
      "datetime": "26-May-2026",
      "details": "The Outcome was intimated within the prescribed timelines under various heads however the same was inadvertently missed under Results Tab therefore uploading the same.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "26-May-2026",
      "details": "Annual Secretarial Compliance Report for the Financial Year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Pharmalabs Ltd has declared <strong>30%</strong> dividend, ex-date: 16 Feb 26",
          "dt": "2026-02-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aarti Pharmalabs Ltd Surges 7.53% to Day's High of Rs 735 — Outperforms Sector by 6.13 Percentage Points

2026-06-23 10:02:34

The Sensex edged up 0.10% on 23 Jun 2026, while Aarti Pharmalabs Ltd surged 7.53% to touch an intraday high of Rs 735, outperforming its Pharmaceuticals & Biotechnology sector by 6.13 percentage points. This sharp single-session gain stands out as a significant stock-specific event amid a broadly positive but modest market advance.

Read full news article

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-23 08:07:58

Aarti Pharmalabs Ltd has experienced a nuanced shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook as of mid-June 2026. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, reflecting both caution and pockets of bullishness amid broader market pressures.

Read full news article

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-22 08:03:39

Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite a 5.01% gain on 22 Jun 2026, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

Aarti Pharmalabs Ltd is Rated Sell

2026-06-21 10:10:35

Aarti Pharmalabs Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-18 08:05:31

Aarti Pharmalabs Ltd has exhibited a subtle shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 1.59%, the stock’s technical indicators present a complex picture, with some signals suggesting cautious optimism while others maintain a bearish undertone.

Read full news article

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Bearish Indicators

2026-06-17 08:06:37

Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a marginal day decline of 0.14%, the stock’s technical parameters, including MACD, RSI, Bollinger Bands, and moving averages, reveal a complex picture that investors must carefully analyse amid broader market pressures.

Read full news article

Aarti Pharmalabs Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-16 08:07:38

Aarti Pharmalabs Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a slight decline in the stock price to ₹639.80, the evolving signals from MACD, RSI, moving averages, and other momentum indicators suggest cautious investor sentiment amid broader market pressures.

Read full news article

Aarti Pharmalabs Ltd is Rated Strong Sell

2026-06-10 10:11:04

Aarti Pharmalabs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 June 2026, providing investors with the most recent and relevant data to assess the company’s outlook.

Read full news article

Aarti Pharmalabs Ltd Faces Intensified Downtrend Amid Technical Weakness

2026-06-09 08:05:27

Aarti Pharmalabs Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters such as MACD, moving averages, and Bollinger Bands, underscores mounting selling pressure amid a challenging market backdrop for the pharmaceuticals sector.

Read full news article

View All News